H5N1

Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. Read More

Vanderbilt researchers are seeking healthy adults ages 18-49 for a study testing a new vaccine against H5N1 influenza, a strain which has the potential to be the next pandemic flu virus. Read More